C 310 GLU 0 -0.486 -0.430 <=B
C 311 PRO 23 -0.570 -3.149 <=B
C 312 SER 3 0.875 0.429 <=B
C 313 ASP 7 2.103 1.056 <=B
C 314 LYS 0 2.147 1.900 <=B
C 315 HIS 12 0.716 -0.747 <=B
C 316 ILE 21 1.628 -0.974 <=B
C 317 LYS 9 2.722 1.374 <=B
C 318 GLU 9 1.694 0.464 <=B
C 319 TYR 26 0.333 -2.696 <=B
C 320 LEU 24 1.787 -1.178 <=B
C 321 ASN 6 2.539 1.557 <=B
C 322 LYS 15 0.562 -1.227 <=B
C 323 ILE 24 1.217 -1.683 <=B
C 324 GLN 10 2.387 0.963 <=B
C 325 ASN 1 2.125 1.766 <=B
C 326 SER 11 1.070 -0.318 <=B
C 327 LEU 28 1.666 -1.746 <=B
C 328 SER 6 2.526 1.545 <=B
C 329 THR 10 2.496 1.059 <=B
C 330 GLU 7 0.897 -0.011 <=B
C 331 TRP 10 -0.369 -1.477 <=B
C 332 SER 30 -1.091 -4.415
C 333 PRO 12 -3.038 -4.069
C 334 CYS 13 -4.917 -5.847
C 335 SER 23 -4.119 -6.291
C 336 VAL 16 -5.359 -6.583
C 337 THR 2 -6.283 -5.791
C 338 CYS 2 -6.614 -6.083
C 339 GLY 4 -5.576 -5.395
C 340 ASN 7 -4.504 -4.791
C 341 GLY 22 -3.720 -5.822
C 342 ILE 21 -3.140 -5.194
C 343 GLN 15 -1.646 -3.182 <=B
C 344 VAL 28 0.195 -3.047 <=B
C 345 ARG 16 1.756 -0.286 <=B
C 346 ILE 20 3.299 0.619 <=B
C 347 LYS 11 3.465 1.801 <=B
C 348 PRO 1 2.264 1.889 <=B
C 349 GLY 6 3.213 2.153 <=B
C 350 SER 21 4.345 1.431 <=B
C 351 ALA 5 3.554 2.570 <=B
C 352 ASN 1 4.439 3.814 <=B
C 353 LYS 18 5.100 2.444 <=B
C 354 PRO 2 4.756 3.979 <=B
C 355 LYS 8 5.046 3.546 <=B
C 356 ASP 0 5.040 4.461 <=B
C 357 GLU 6 4.909 3.655 <=B
C 358 LEU 24 4.900 1.576 <=B
C 359 ASP 4 5.055 4.014 <=B
C 360 TYR 11 3.888 2.176 <=B
C 361 ALA 0 3.539 3.132 <=B
C 362 ASN 11 3.997 2.272 <=B
C 363 ASP 17 4.014 1.598 <=B
C 364 ILE 27 3.547 0.034 <=B
C 365 GLU 15 2.200 0.222 <=B
C 366 LYS 22 1.441 -1.255 <=B
C 367 LYS 11 -1.175 -2.305 <=B
C 368 ILE 7 -3.215 -3.650 <=B
C 369 CYS 21 -4.388 -6.298
C 370 LYS 1 -5.239 -4.752
C 371 MET 13 -6.305 -7.075
C 372 GLU 0 -6.087 -5.387
C 373 LYS 7 -6.643 -6.684
C 374 CYS 8 -6.895 -7.022

Identified 48 B-Cell epitope residues out of 65 total residues